<h3 class="text-center">Program name: Critical Dose Drug Considerations for Post-Transplant Patients</h3>

<h4 class="mt-5">Introduction</h4>
<p class="text-justify">
    The purpose of this program is to provide Canadian pharmacists with the knowledge
    and tools to make informed decisions when considering substitutions for critical dose
    drugs, also known as narrow therapeutic index drugs, for a patient post-transplant.
</p>

<h4 class="mt-4">Learning objectives</h4>
<p class="text-justify">
    Upon completion of the program, participants will be able to:
    <ul>
        <li>Define critical dose drugs, also known as narrow therapeutic index drugs.</li>
        <li>
            Identify considerations for substitutions between different immunosuppressant drug formulations based on pharmacokinetic data and patient outcomes,
            including brand name, subsequent entry formulations, and immediate- vs. extended-release formulations.
        </li>
        <li>
            Outline the key considerations and appropriate steps for managing potential switches in immunosuppressant drug formulation after transplant.
        </li>
    </ul>
</p>

<h4 class="mt-4">Accreditation statement</h4>

<h4 class="mt-4">Scientific Planning Committee</h4>
<p class="text-justify">
    Transplant Specialist: Dr. Ramesh Prasad MBBS, MSc, MA, PhD, FRCPC, FACP, FASN, FASH, FAST (Ontario)
</p>
<p class="text-justify">
    Pharmacists:
    <ul>
        <li>Jennifer Harrison (lead) BPharm, MSc (Ontario)</li>
        <li>Christian Coursol BPharm, MSc (Québec)</li>
        <li>Élisabeth Gélinas-Lemay BPharm, MSc (Québec)</li>
    </ul>
</p>

<h4 class="mt-4">Scientific Planning Committee Disclosures</h4>

<h4 class="mt-4">Commercial Support Disclosure</h4>
<p class="text-justify">This program has received financial support from Astellas Pharma Canada Inc. in the form of an educational grant</p>
<p class="text-justify">This program has received in-kind support from Astellas Pharma Canada Inc. in the form of logistical support</p>

<h4 class="mt-4">Target audience</h4>